» Articles » PMID: 26430598

Intramedullary Spinal Cord Tumors: Part I-Epidemiology, Pathophysiology, and Diagnosis

Overview
Journal Global Spine J
Publisher Sage Publications
Date 2015 Oct 3
PMID 26430598
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design Broad narrative review. Objectives Intramedullary spinal cord tumors (IMSCT) are rare neoplasms that can potentially lead to severe neurologic deterioration, decreased function, poor quality of life, or death. As such, a better understanding of these lesions is needed. The following article, part one of a two-part series, addresses IMSCT with regards to their epidemiology, histology, pathophysiology, imaging characteristics, and clinical manifestations. Methods The authors performed an extensive review of the peer-reviewed literature addressing the aforementioned objectives. Results Numerous IMSCT exist with varying epidemiology. Each IMSCT has its own hallmark characteristics and may vary with regards to how aggressively they invade the spinal cord. These lesions are often difficult to detect and are often misdiagnosed. Furthermore, radiographically and clinically, these lesions may be difficult to distinguish from one another. Conclusions Awareness and understanding of IMSCT is imperative to facilitate an early diagnosis and plan management.

Citing Articles

Safety and Efficacy of Stereotactic Radiosurgery in the Management of Primary Spinal Cord Glioblastoma: A Case Report.

Lazzari G, Montagna A, Benevento I, DAndrea B, Metallo V, Tucciariello R Cancer Manag Res. 2025; 17:349-355.

PMID: 39990275 PMC: 11847440. DOI: 10.2147/CMAR.S509635.


Liquid Biopsy for Spinal Tumors: On the Frontiers of Clinical Application.

Tan S, Bettegowda C, Yip S, Sahgal A, Rhines L, Reynolds J Global Spine J. 2025; 15(1_suppl):16S-28S.

PMID: 39801114 PMC: 11726521. DOI: 10.1177/21925682231222012.


The impact of adjuvant radiotherapy on overall survival in spinal low-grade gliomas: a propensity score-matched analysis.

El-Hajj V, Ranganathan S, Hoang H, Ghaith A, Bydon M, Elmi-Terander A J Neurooncol. 2024; 171(3):629-636.

PMID: 39527384 PMC: 11729206. DOI: 10.1007/s11060-024-04880-3.


Astrocytomas of the spinal cord.

Tonn J, Teske N, Karschnia P Neurooncol Adv. 2024; 6(Suppl 3):iii48-iii56.

PMID: 39430394 PMC: 11485950. DOI: 10.1093/noajnl/vdad166.


Spinal ependymal tumors.

Westphal M, Mohme M Neurooncol Adv. 2024; 6(Suppl 3):iii57-iii65.

PMID: 39430387 PMC: 11485896. DOI: 10.1093/noajnl/vdad138.


References
1.
Brotchi J, Fischer G . Spinal cord ependymomas. Neurosurg Focus. 2006; 4(5):e2. DOI: 10.3171/foc.1998.4.5.5. View

2.
Rykken J, Diehn F, Hunt C, Schwartz K, Eckel L, Wood C . Intramedullary spinal cord metastases: MRI and relevant clinical features from a 13-year institutional case series. AJNR Am J Neuroradiol. 2013; 34(10):2043-9. PMC: 7965414. DOI: 10.3174/ajnr.A3526. View

3.
Price R, Johnson W . The central nervous system in childhood leukemia. I. The arachnoid. Cancer. 1973; 31(3):520-33. DOI: 10.1002/1097-0142(197303)31:3<520::aid-cncr2820310306>3.0.co;2-2. View

4.
CHASON J, WALKER F, LANDERS J . Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study. Cancer. 1963; 16:781-7. DOI: 10.1002/1097-0142(196306)16:6<781::aid-cncr2820160614>3.0.co;2-m. View

5.
Decker H, Neuhaus C, Jauch A, Speicher M, Ried T, Bujard M . Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH. Hum Genet. 1996; 97(6):770-6. DOI: 10.1007/BF02346188. View